Researcher
Stefaan Van Gool
- Disciplines:Paediatrics and neonatology, Nursing
Affiliations
- Inborn Errors of Immunity (Lab)
Member
From1 Jan 2012 → 30 Sep 2016
Projects
1 - 7 of 7
- Local and systemic immune interactions in malignant gliomasFrom1 Aug 2013 → 19 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Computational Horizons in Cancer: Developing Meta- and Hyper-Multiscale Models and Repositories for In Silico Oncology.From1 Apr 2013 → 31 Mar 2017Funding: General Activities (Annex IV)
- Optimalization of immunotherapy in uterine sarcoma.From1 Oct 2012 → 30 Sep 2013Funding: BOF - Other initiatives
- Evaluation of galectin-1 targeting drugs in combination with chemo-immunotherapy in the treatment of high-grade glioma.From1 Aug 2012 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
- Immunotherapy with subcutaneous immunogenic autologous lysate against glioblastomaFrom1 Sep 2011 → 25 Oct 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Comparison of the immunomodulatory capacities of multipotent adult progenitor cells (MAPC) and mesenchymal stem cells (MSC) in graft-versus-host disease (GVHD).From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Lineage plasticity of regulatory T cells in high-grade glioma as a tool to improve immunotherapy.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 97
- Immunotherapy with subcutaneous immunogenic autologous lysate against glioblastoma(2019)
Authors: Jochen Belmans, Dominique Bullens, Jean-Pierre Locquet, Stefaan Van Gool
- Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group(2016)
Authors: Stefaan Van Gool
Pages: 1178 - 1186 - Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration(2016)
Authors: Matthias Van Woensel, Brecht Steelant, Stefaan Van Gool, Holger Gerhardt, Steven De Vleeschouwer
Pages: 71 - 81 - mRNA electroporation of dendritic cells with WT1, survivin and TriMix (a mixture of caTLR4, CD40L, and CD70)(2016)
Authors: An Coosemans, Sandra Tuyaerts, Stefaan Van Gool, Ignace Vergote, Frédéric Amant
Pages: 3 - 320 - Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma(2016)
Authors: Abhishek Garg, Lien Vandenberk, Stefaan Van Gool, Patrizia Agostinis
- Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma(2016)
Authors: Lien Vandenberk, Abhishek Garg, Jochen Belmans, Monique Beullens, Patrizia Agostinis, Steven De Vleeschouwer, Stefaan Van Gool
- ID8-Fluc: a syngeneic mouse model for ovarian cancer(2015)
Authors: Thaïs Baert, Tina Verschuere, anais Van Hoylandt, Rik Gijsbers, Stefaan Van Gool, Ignace Vergote, An Coosemans
Pages: 619 - Brain tumor immunotherapy: what have we learned so far?(2015)
Authors: Stefaan Van Gool
- Tumour relapse prediction using multiparametric MR data recorded during follow-up of GBM patients(2015)
Authors: Diana Sima, Frederik Maes, Stefaan Van Gool, Stefan Sunaert, Uwe Himmelreich, Sabine Van Huffel
Pages: 1 - 13 - CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity(2015)
Authors: Ahmad Kasran, Stefaan Van Gool, Jan Ceuppens
Pages: 1832 - 1841